Toronto, Ontario–(Newsfile Corp. – November 28, 2023) – LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) (“LevelJump” or the “Company”), a Canadian leader in B2B telehealth solutions, is pleased to announce that it has declared a quarterly dividend on its Class A Series 1 12% Cumulative Redeemable Convertible Non-Voting Preferred Shares (the “A-1 Preferred Shares”).
The dividend is $0.03 per share and is payable to shareholders of record of the A-1 Preferred Shares as of September 30, 2023.
“We are thrilled to offer returns to our valued investors. As we work to increase our revenue streams and current operations, we remain focused delivering tangible results and increasing shareholder value.” said Mitch Geisler, CEO.
Appointment of MNP LLP as Auditor
The Company also wishes to announce that it has appointed MNP LLP as auditor of the Company, effective as of October 13, 2023. In connection with this change, the Company’s previous auditors have confirmed there are no reportable disagreements with the Company within the meaning of NI 51-102.
A change of auditor reporting package prepared in accordance with NI 51-102 has been posted to SEDAR+. In addition, a copy of the package will be included with the next mailing of annual meeting materials.
About LevelJump Healthcare
LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its IHF’s (Independent Healthcare Facilities). JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.
ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.
Chief Executive Officer
Investor Relations Manager
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
This news release contains “forward-looking information” within the meaning of applicable securities laws relating to the Company’s business plans and the outlook of the Company’s industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).
Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/188936